Perrigo Delivering Opill Sales Within A Month, Launches ‘Energize’ Efficiency Project Immediately

Perrigo says 2024 results will be slowed by investment in companywide efficiency project including staff reductions. After Opill’s expected launch by late March, sales will be dilutive to earnings for the first year partly due to investments in the brand, primarily at retailers and online in Q2.

Perrigo Company PLC doesn’t downplay the likely boost to its revenues from the pending launch of Opill as the first oral contraceptive available OTC in the US, but the consumer health products giant also isn’t underestimating challenges to its growth.

Perrigo says its 2024 results will be slowed by investment in a companywide overhaul including staff reductions and organizational streamlining.